Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4947
Title: The use of continuous electronic prescribing data to infer trends in antimicrobial consumption and estimate the impact of stewardship interventions in hospitalized children
Authors: Kwok, M.
Bamford, A.
Konstanty, P.
Hatcher, J.
Dixon, G.
Diggle, P. J.
Standing, J. F.
Irwin, Adam 
Booth, J.
Channon-Wells, S.
Issue Date: 2021
Source: 76, (9), 2021, p. 2464-2471
Pages: 2464-2471
Journal: Journal of Antimicrobial Chemotherapy
Abstract: Background: Understanding antimicrobial consumption is essential to mitigate the development of antimicrobial resistance, yet robust data in children are sparse and methodologically limited. Electronic prescribing systems provide an important opportunity to analyse and report antimicrobial consumption in detail. Objectives: We investigated the value of electronic prescribing data from a tertiary children's hospital to report temporal trends in antimicrobial consumption in hospitalized children and compare commonly used metrics of antimicrobial consumption. Methods: Daily measures of antimicrobial consumption [days of therapy (DOT) and DDDs] were derived from the electronic prescribing system between 2010 and 2018. Autoregressive moving-average models were used to infer trends and the estimates were compared with simulated point prevalence surveys (PPSs). Results: More than 1.3 million antimicrobial administrations were analysed. There was significant daily and seasonal variation in overall consumption, which reduced annually by 1.77% (95% CI 0.50% to 3.02%). Relative consumption of meropenem decreased by 6.6% annually (95% CI -3.5% to 15.8%) following the expansion of the hospital antimicrobial stewardship programme. DOT and DDDs exhibited similar trends for most antimicrobials, though inconsistencies were observed where changes to dosage guidelines altered consumption calculation by DDDs, but not DOT. PPS simulations resulted in estimates of change over time, which converged on the model estimates, but with much less precision. Conclusions: Electronic prescribing systems offer significant opportunities to better understand and report antimicrobial consumption in children. This approach to modelling administration data overcomes the limitations of using interval data and dispensary data. It provides substantially more detailed inferences on prescribing patterns and the potential impact of stewardship interventions.L20143944972021-09-09
2021-12-23
DOI: 10.1093/jac/dkab187
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2014394497&from=exporthttp://dx.doi.org/10.1093/jac/dkab187 |
Keywords: seasonal variation;tertiary care center;time series analysis;trend study;prescribing practice;amikacinamoxicillin plus clavulanic acid;antiinfective agent;ceftazidime;ciprofloxacin;cotrimoxazole;flucloxacillin;meropenem;metronidazole;piperacillin plus tazobactam;vancomycin;antibiotic resistance;antimicrobial stewardship;article;child;clinical decision support system;drug use;electronic prescribing;England;hospitalized child;human;pediatric hospital;point prevalence
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

54
checked on Mar 27, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.